Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Relation of Patellofemoral Joint Alignment, Morphology, and Radiographic Osteoarthritis to Frequent Anterior Knee Pain: The MOST Study.

Macri EM, Neogi T, Tolstykh I, Widjajahakim R, Lewis CE, Torner JC, Nevitt MC, Roux M, Stefanik JJ.

Arthritis Care Res (Hoboken). 2019 Jun 14. doi: 10.1002/acr.24004. [Epub ahead of print]

PMID:
31199605
2.

Association of diabetes mellitus and biomarkers of abnormal glucose metabolism with incident radiographic knee osteoarthritis.

Rogers-Soeder TS, Lane NE, Walimbe M, Schwartz AV, Tolstykh I, Felson DT, Lewis CE, Segal NA, Nevitt MC; Multicenter Osteoarthritis (MOST) Study Group.

Arthritis Care Res (Hoboken). 2018 Nov 12. doi: 10.1002/acr.23809. [Epub ahead of print]

PMID:
30418707
3.

Association of Varus Knee Thrust During Walking With Worsening Western Ontario and McMaster Universities Osteoarthritis Index Knee Pain: A Prospective Cohort Study.

Wink AE, Gross KD, Brown CA, Lewis CE, Torner J, Nevitt MC, Tolstykh I, Sharma L, Felson DT.

Arthritis Care Res (Hoboken). 2018 Sep 22. doi: 10.1002/acr.23766. [Epub ahead of print]

PMID:
30242985
4.

Brief Report: Leg Length Inequality and Hip Osteoarthritis in the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.

Kim C, Nevitt M, Guermazi A, Niu J, Clancy M, Tolstykh I, Jungmann PM, Lane NE, Segal NA, Harvey WF, Lewis CE, Felson DT.

Arthritis Rheumatol. 2018 Oct;70(10):1572-1576. doi: 10.1002/art.40537.

PMID:
29700988
5.

Varus thrust during walking and the risk of incident and worsening medial tibiofemoral MRI lesions: the Multicenter Osteoarthritis Study.

Wink AE, Gross KD, Brown CA, Guermazi A, Roemer F, Niu J, Torner J, Lewis CE, Nevitt MC, Tolstykh I, Sharma L, Felson DT.

Osteoarthritis Cartilage. 2017 Jun;25(6):839-845. doi: 10.1016/j.joca.2017.01.005. Epub 2017 Jan 16.

6.

Baseline trabecular bone and its relation to incident radiographic knee osteoarthritis and increase in joint space narrowing score: directional fractal signature analysis in the MOST study.

Podsiadlo P, Nevitt MC, Wolski M, Stachowiak GW, Lynch JA, Tolstykh I, Felson DT, Segal NA, Lewis CE, Englund M.

Osteoarthritis Cartilage. 2016 Oct;24(10):1736-1744. doi: 10.1016/j.joca.2016.05.003. Epub 2016 May 7.

7.

Symptoms of Knee Instability as Risk Factors for Recurrent Falls.

Nevitt MC, Tolstykh I, Shakoor N, Nguyen US, Segal NA, Lewis C, Felson DT; Multicenter Osteoarthritis Study Investigators.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1089-97. doi: 10.1002/acr.22811.

8.

Association of hip pain with radiographic evidence of hip osteoarthritis: diagnostic test study.

Kim C, Nevitt MC, Niu J, Clancy MM, Lane NE, Link TM, Vlad S, Tolstykh I, Jungmann PM, Felson DT, Guermazi A.

BMJ. 2015 Dec 2;351:h5983. doi: 10.1136/bmj.h5983.

9.

Do persons with asymmetric hip pain or radiographic hip OA have worse pain and structure outcomes in the knee opposite the more affected hip? Data from the Osteoarthritis Initiative.

Joseph GB, Hilton JF, Jungmann PM, Lynch JA, Lane NE, Liu F, McCulloch CE, Tolstykh I, Link TM, Nevitt MC.

Osteoarthritis Cartilage. 2016 Mar;24(3):427-35. doi: 10.1016/j.joca.2015.10.001. Epub 2015 Oct 20.

10.

High plasma levels of vitamin C and E are associated with incident radiographic knee osteoarthritis.

Chaganti RK, Tolstykh I, Javaid MK, Neogi T, Torner J, Curtis J, Jacques P, Felson D, Lane NE, Nevitt MC; Multicenter Osteoarthritis Study Group (MOST).

Osteoarthritis Cartilage. 2014 Feb;22(2):190-6. doi: 10.1016/j.joca.2013.11.008. Epub 2013 Nov 28.

11.

Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?

Omachi TA, Gregorich SE, Eisner MD, Penaloza RA, Tolstykh IV, Yelin EH, Iribarren C, Dudley RA, Blanc PD.

Med Care. 2013 Aug;51(8):740-7. doi: 10.1097/MLR.0b013e318298082f.

12.

Vitamin K deficiency is associated with incident knee osteoarthritis.

Misra D, Booth SL, Tolstykh I, Felson DT, Nevitt MC, Lewis CE, Torner J, Neogi T.

Am J Med. 2013 Mar;126(3):243-8. doi: 10.1016/j.amjmed.2012.10.011.

13.

Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts.

Iribarren C, Tolstykh IV, Miller MK, Sobel E, Eisner MD.

Am J Epidemiol. 2012 Dec 1;176(11):1014-24. doi: 10.1093/aje/kws181. Epub 2012 Nov 8.

PMID:
23139248
14.

Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system.

Iribarren C, Tolstykh IV, Miller MK, Eisner MD.

Ann Allergy Asthma Immunol. 2010 May;104(5):371-7. doi: 10.1016/j.anai.2010.03.004.

PMID:
20486326
15.

Pre-radiographic MRI findings are associated with onset of knee symptoms: the most study.

Javaid MK, Lynch JA, Tolstykh I, Guermazi A, Roemer F, Aliabadi P, McCulloch C, Curtis J, Felson D, Lane NE, Torner J, Nevitt M.

Osteoarthritis Cartilage. 2010 Mar;18(3):323-8. doi: 10.1016/j.joca.2009.11.002. Epub 2009 Nov 11.

16.

Socioeconomic status, race and COPD health outcomes.

Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, Ackerson LM, Sanchez G, Tolstykh I, Iribarren C.

J Epidemiol Community Health. 2011 Jan;65(1):26-34. doi: 10.1136/jech.2009.089722. Epub 2009 Oct 23.

17.

A comparison of dedicated 1.0 T extremity MRI vs large-bore 1.5 T MRI for semiquantitative whole organ assessment of osteoarthritis: the MOST study.

Roemer FW, Lynch JA, Niu J, Zhang Y, Crema MD, Tolstykh I, El-Khoury GY, Felson DT, Lewis CE, Nevitt MC, Guermazi A.

Osteoarthritis Cartilage. 2010 Feb;18(2):168-74. doi: 10.1016/j.joca.2009.08.017. Epub 2009 Sep 9.

18.

[Isolation and study of antibiotic INA-1132 (chlorothricin), produced by actinomycete strain].

Terekhova LP, Galatenko OA, Trenin AS, Tolstykh IV, Zenkova VA, Zhukhlistova NE, Ol'khovatova OL, Malkina ND, Boĭkova IuV, Ustinova EV, Katrukha GS.

Antibiot Khimioter. 2008;53(7-8):3-7. Russian.

PMID:
19227116
19.

Risk factors for death in adults with severe asthma.

Omachi TA, Iribarren C, Sarkar U, Tolstykh I, Yelin EH, Katz PP, Blanc PD, Eisner MD.

Ann Allergy Asthma Immunol. 2008 Aug;101(2):130-6. doi: 10.1016/S1081-1206(10)60200-1.

20.

COPD as a systemic disease: impact on physical functional limitations.

Eisner MD, Blanc PD, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, Iribarren C.

Am J Med. 2008 Sep;121(9):789-96. doi: 10.1016/j.amjmed.2008.04.030.

21.

Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease.

Eisner MD, Iribarren C, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, Blanc PD.

Am J Epidemiol. 2008 May 1;167(9):1090-101. doi: 10.1093/aje/kwn025. Epub 2008 Mar 14.

22.

Community-level social capital and recurrence of acute coronary syndrome.

Scheffler RM, Brown TT, Syme L, Kawachi I, Tolstykh I, Iribarren C.

Soc Sci Med. 2008 Apr;66(7):1603-13. doi: 10.1016/j.socscimed.2007.12.007. Epub 2008 Jan 28.

PMID:
18222582
23.

Effect of race on asthma management and outcomes in a large, integrated managed care organization.

Erickson SE, Iribarren C, Tolstykh IV, Blanc PD, Eisner MD.

Arch Intern Med. 2007 Sep 24;167(17):1846-52.

PMID:
17893305
24.

Body composition and functional limitation in COPD.

Eisner MD, Blanc PD, Sidney S, Yelin EH, Lathon PV, Katz PP, Tolstykh I, Ackerson L, Iribarren C.

Respir Res. 2007 Jan 29;8:7.

25.

Sex and racial/ethnic disparities in outcomes after acute myocardial infarction: a cohort study among members of a large integrated health care delivery system in northern California.

Iribarren C, Tolstykh I, Somkin CP, Ackerson LM, Brown TT, Scheffler R, Syme L, Kawachi I.

Arch Intern Med. 2005 Oct 10;165(18):2105-13.

PMID:
16217000
26.

The impact of allergy and pulmonary specialist care on emergency asthma utilization in a large managed care organization.

Erickson S, Tolstykh I, Selby JV, Mendoza G, Iribarren C, Eisner MD.

Health Serv Res. 2005 Oct;40(5 Pt 1):1443-65.

27.

Intensive care unit admission for asthma: a marker for severe disease.

Eisner MD, Boland M, Tolstykh I, Mendoza G, Iribarren C.

J Asthma. 2005 Jun;42(5):315-23.

PMID:
16036406
28.

Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure.

Iribarren C, Go AS, Tolstykh I, Sidney S, Johnston SC, Spring DB.

J Womens Health (Larchmt). 2004 May;13(4):381-9; discussion 390-2.

PMID:
15186654
29.

Are patients with asthma at increased risk of coronary heart disease?

Iribarren C, Tolstykh IV, Eisner MD.

Int J Epidemiol. 2004 Aug;33(4):743-8. Epub 2004 May 6.

PMID:
15131088
30.

[Screening of microbial secondary metabolites inhibiting cholesterol biosynthesis with the use of hepatoblastoma G2].

Trenin AS, Terekhova LP, Tolstykh IV, Zenkova VA, Fedorova GB, Katrukha GS.

Antibiot Khimioter. 2003;48(1):3-8. Russian.

PMID:
12741315
31.

[Specifics of sorption after purification of permeates produced by nanofiltration of washing water in pressurized modules].

Shumilina IV, Krivobok SM, Tolstykh IM.

Aviakosm Ekolog Med. 2000;34(5):62-5. Russian.

PMID:
11816413
32.

[The hypolipidemic action of antibiotic 86/88 (enniatin B) in a hepatoblastoma G2 cell culture].

Trenin AS, Tolstykh IV, Terekhova LP, Zenkova VA, Makarova MO, Gladkikh EG, Bychkova OP, Katrujha GS, Dudnik IuV.

Antibiot Khimioter. 2000;45(4):6-9. Russian.

PMID:
10851642
33.

[Actinoplanes brasiliensis INA 3802--a producer of peptide antibiotics].

Terekhova LP, Galatenko OA, Laĭko AV, Sumarukova IG, Golova TP, Tolstykh IV, Kozlova IuI.

Antibiot Khimioter. 1999;44(4):5-8. Russian.

PMID:
10483488
34.

[Production of griseoviridin and etamycin by the new culture, Streptomyces albolongus].

Terekhova LP, Galatenko OA, Kuliaeva VV, Tolstykh IV, Golova TP, Katrukha GS, Zhukhmistova NE, Ol'khovatova OL, Malkina ND, Boĭkova IuV.

Antibiot Khimioter. 1992 Dec;37(12):19-21. Russian.

PMID:
1304120
35.

[Early identification of streptothricin group antibiotics].

Terekhova LP, Novozhenov MIu, Tolstykh IV, Brazhnikova MG.

Antibiot Khimioter. 1991 Mar;36(3):15-7. Russian.

PMID:
1652234
36.

[Actinomadura species as antibiotic producers].

Terekhova LP, Galatenko OA, Preobrazhenskaia TP, Tolstykh IV, Ol'khovatova OL, Malkina ND, Rubtsova EV.

Antibiot Khimioter. 1991 Jan;36(1):3-5. Russian.

PMID:
2053819
37.

[The antineoplastic antibiotic polypeptide 308 produced by Actinomadura recticatena. Its isolation and physicochemical properties].

Fedorova GB, Brazhnikova MG, Borisova VN, Tolstykh IV, Volkolupova OP.

Antibiot Khimioter. 1988 Jun;33(6):415-20. Russian.

PMID:
3421765
38.

[The antibiotic varigomycin--a new representative of the carbonyl-conjugated pentaenes].

Gauze GF, Brazhnikova MG, Borisova VN, Fedorova GB, Tolstykh IV.

Antibiot Med Biotekhnol. 1986 Sep;31(9):659-63. Russian.

PMID:
3777892
39.

The structure of nocamycin, a new antitumor antibiotic.

Horváth G, Brazhnikova MG, Konstantinova NV, Tolstykh IV, Potapova NP.

J Antibiot (Tokyo). 1979 Jun;32(6):555-8.

40.

[Physicochmemical characteristics of the new antineoplastic antibiotic, nocamycin].

Brazhnikova MG, Konstantinova NV, Potapova NP, Tolstykh IV.

Antibiotiki. 1977 Jun;22(6):486-9. Russian.

PMID:
18980
41.

[Extraction of rifamycin B from native and aqueous solutions].

Tolstykh IV, Konstantinova NV, Grishin IA, Pokras LS.

Antibiotiki. 1975 Mar;20(3):222-5. Russian.

PMID:
237467
42.

[Isolation and physicochemical properties of the antineoplastic antibiotic 1719].

Konstantinova NV, Grishin IA, Kovsharova IN, Tolstykh IV, Myshentseva TM.

Antibiotiki. 1972 Aug;17(8):680-3. Russian. No abstract available.

PMID:
4674504
43.

[Extraction method for production of the antibiotic sibiromycin].

Pokras LS, Krugliak EB, Tolstykh IV, Brazhnikova MG.

Antibiotiki. 1972 Aug;17(8):697-701. Russian. No abstract available.

PMID:
4635250
44.

[Isolation of formylpyrrol derivative from the inactivation products of sibiromycin].

Mezentsev AS, Kontantinova NV, Kuleiava VV, Tolstykh IV, Brazhnikova MG.

Antibiotiki. 1971 Jan;16(1):3-6. Russian. No abstract available.

PMID:
5553275
45.

[Quantitative determination of the antitumor antibiotic sibiromycin in preparations and culture liquid].

Konstantinova NV, Tolstykh IV, Brazhnikova MG.

Antibiotiki. 1970 Apr;15(4):304-7. Russian. No abstract available.

PMID:
5489276
46.

[Chemical method for determination of ristomycin].

Brazhnikova MG, Lomakina NN, Pokras LS, Tolstykh IV.

Antibiotiki. 1967 Feb;12(2):129-32. Russian. No abstract available.

PMID:
4298087
47.

[ISOLATION AND PROPERTIES OF RISTOMYCIN].

BRAZHNIKOVA MG, LOMAKINA NN, LAVROVA MF, TOLSTYKH IV, IURINA MS, KLIUEVA LM.

Antibiotiki. 1963 May;8:392-6. Russian. No abstract available.

PMID:
14076081

Supplemental Content

Loading ...
Support Center